Westerkirk Capital Inc. Reduces Position in Nutrien Ltd. $NTR

Westerkirk Capital Inc. decreased its holdings in Nutrien Ltd. (NYSE:NTR) by 93.4% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,360 shares of the company’s stock after selling 19,100 shares during the quarter. Westerkirk Capital Inc.’s holdings in Nutrien were worth $84,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of NTR. Swiss Life Asset Management Ltd boosted its stake in shares of Nutrien by 23.6% during the 3rd quarter. Swiss Life Asset Management Ltd now owns 79,770 shares of the company’s stock valued at $4,691,000 after buying an additional 15,230 shares during the last quarter. Van ECK Associates Corp raised its holdings in Nutrien by 1.4% in the third quarter. Van ECK Associates Corp now owns 1,854,650 shares of the company’s stock valued at $108,901,000 after acquiring an additional 25,588 shares in the last quarter. MH & Associates Securities Management Corp ADV bought a new position in Nutrien during the 4th quarter valued at $1,967,000. Hudson Bay Capital Management LP boosted its stake in Nutrien by 190.3% during the 3rd quarter. Hudson Bay Capital Management LP now owns 116,312 shares of the company’s stock valued at $6,829,000 after acquiring an additional 76,244 shares during the last quarter. Finally, Metis Global Partners LLC increased its position in shares of Nutrien by 37.8% in the 3rd quarter. Metis Global Partners LLC now owns 220,648 shares of the company’s stock worth $12,958,000 after purchasing an additional 60,491 shares during the last quarter. Institutional investors and hedge funds own 63.10% of the company’s stock.

Nutrien Price Performance

Shares of NYSE:NTR opened at $66.29 on Wednesday. The company has a market cap of $31.82 billion, a PE ratio of 13.50, a P/E/G ratio of 0.62 and a beta of 0.60. Nutrien Ltd. has a fifty-two week low of $53.03 and a fifty-two week high of $85.36. The firm has a 50-day simple moving average of $71.91 and a 200 day simple moving average of $69.04. The company has a quick ratio of 0.59, a current ratio of 1.24 and a debt-to-equity ratio of 0.35.

Nutrien (NYSE:NTR) last issued its earnings results on Wednesday, May 6th. The company reported $0.51 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.48 by $0.03. The firm had revenue of $6.05 billion for the quarter, compared to analysts’ expectations of $5.30 billion. Nutrien had a net margin of 8.58% and a return on equity of 8.84%. Nutrien’s revenue was up 18.5% on a year-over-year basis. During the same quarter last year, the company posted $0.11 earnings per share. On average, sell-side analysts anticipate that Nutrien Ltd. will post 5.45 EPS for the current year.

Nutrien Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 17th. Investors of record on Tuesday, June 30th will be given a dividend of $0.55 per share. The ex-dividend date is Tuesday, June 30th. This represents a $2.20 dividend on an annualized basis and a yield of 3.3%. Nutrien’s payout ratio is currently 44.81%.

Analysts Set New Price Targets

Several brokerages have recently commented on NTR. Canadian Imperial Bank of Commerce reduced their price target on shares of Nutrien from $90.00 to $88.00 and set an “outperformer” rating on the stock in a research report on Thursday, April 30th. Zacks Research lowered Nutrien from a “strong-buy” rating to a “hold” rating in a report on Monday, March 2nd. Bank of America upgraded Nutrien from a “neutral” rating to a “buy” rating and set a $82.00 price objective on the stock in a research note on Thursday, April 30th. Scotiabank lifted their target price on Nutrien from $75.00 to $80.00 and gave the stock a “sector perform” rating in a research report on Monday, May 11th. Finally, Barclays boosted their price target on Nutrien from $70.00 to $80.00 and gave the company an “equal weight” rating in a report on Tuesday, March 3rd. Eleven equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $81.71.

About Nutrien

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.